Download PDF
Thromb Haemost 1995; 74(01): 240-245
DOI: 10.1055/s-0038-1642684
Colloquium
Disorders Causing Thrombocytopenia
Schattauer GmbH Stuttgart

Thrombotic Thrombocytopenic Purpura

Joel L Moake
Baylor College of Medicine and Rice University, Houston, Texas, USA
› Author Affiliations
Further Information

Publication History

Publication Date:
09 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Moschcowitz E. Hyaline thrombosis of the terminal arterioles and capillaries: A hitherto undescribed disease. Proceedings of the New York Pathological Society 1924; 24: 21-24
    PubMedGoogle Scholar
  • 2 Baehr G, Klemperer P, Schifrin A. An acute febrile anemia with thrombocytopenic purpura with diffuse platelet thrombosis of capillaries and arterioles. Transactions of the Association of American Physicians 1936; 65: 43-58
    PubMedGoogle Scholar
  • 3 Harkness DR, Byrnes JJ, Lian EC Y, Williams WD, Hensley CT. Hazard of platelet transfusion in thrombotic thrombocytopenic purpura. JAMA 1981; 246: 1931-1933
    CrossrefPubMedGoogle Scholar
  • 4 Asada Y, Sumiyoshi A, Hayashi T, Suzumiya K, Kaketani K. Immunohistochemistry of vascular lesions in thrombotic thrombocytopenic purpura with special reference to factor VIII related antigen . Thrombosis Res 1985; 38: 469-479
    CrossrefPubMedGoogle Scholar
  • 5 Byrnes JJ, and Moake JL. Thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome evolving concepts of pathogenesis and therapy. Clinics in Haematology 1986; 15: 413-442
    PubMedGoogle Scholar
  • 6 Leaf AN, Laubenstein LJ, Raphael E, Hochster H, Baez L, Karpatkin S. Thrombotic thrombocytopenic purpura associated with immunodeficiency virus type 1 (HIV-1) infection. Ann Intern Med 1988; 109: 194-197
    CrossrefPubMedGoogle Scholar
  • 7 Nair JM, Belleview R, Bertoni M, Dosik H. Thrombotic thrombocytopenic purpura in patients with the acquired immunodeficiency syndrome (AIDS) related complex a report of two cases. Ann Intern Med 1988; 109: 209-212
    CrossrefPubMedGoogle Scholar
  • 8 Thompson CE, Damon LE, Ries CA, Linker CA. Thrombotic microangiopathies in the 1980’s clinical features response to treatment and the impact of the human immunodeficiency virus epidemic. Blood 1992; 80: 1890-1895
    PubMedGoogle Scholar
  • 9 Dixon AC, Kwock DW, Nakumura JM, Yanagihara ET, Saiki SM, Bodner AJ, Alexander SS. Thrombotic thrombocytopenic purpura and the human T-lymphotropic virus type 1 (HTLV-1). Ann Intern Med 1989; 110: 93-94
    CrossrefPubMedGoogle Scholar
  • 10 Moake J, Chintagumpala M, Turner N, McPherson P, Nolasco L, Steuber C, Santiago-Borrero P, Horowitz M, Pehta J. Solvent/ detergent-treated plasma suppresses shear-induced platelet aggregation and prevents episodes of thrombotic thrombocytopenic purpura. Blood 1994; 84: 490-497
    PubMedGoogle Scholar
  • 11 Byrnes JJ. Plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Sem Thromb Hemostas 1981; 7: 9-14
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Miura M, Koizumi S, Nakamura K, OhYio T, Tachinami T, Yamagami M. Efficacy of several plasma components in a young boy with chronic thrombocytopenia and hemolytic anemia who responds repeatedly to normal plasma infusions. Am J Hematol 1984; 17: 307-319
    CrossrefPubMedGoogle Scholar
  • 13 Chintagumpala M, Hurwitz R, Moake J, Mahoney D, Steuber C. Chronic relapsing thrombotic thrombocytopenic purpura in infants with large von Willebrand factor multimers during remission. J Pediatr 1992; 120: 49-53
    CrossrefPubMedGoogle Scholar
  • 14 Siddiqui FA, Lian EC Y. Novel platelet-agglutinating protein from a thrombotic thrombocytopenic purpura plasma. J Clin Invest 1985; 76: 1330-1337
    CrossrefPubMedGoogle Scholar
  • 15 Chen S, Lian EC Y. Purification and some properties of a 59KDa platelet-aggregating protein from the plasma of a patient with thrombotic thrombocytopenic purpura. Blood 1988; 72: 318a (Abst)
    PubMedGoogle Scholar
  • 16 Moore JC, Murphy WG, Kelton JG. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein Ilb/IIIa an explanation for platelet aggregation in thrombotic thrombocytopenic purpura. Br J Haematol 1990; 74: 457-464
    CrossrefPubMedGoogle Scholar
  • 17 Moake JL, Rudy CK, Troll JH, Weinstein MJ, Colannino NM, Azocar J, Seder RH, Hong SL, Deykin D. Unusually large plasma factor VIII von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 1982; 307: 1432-1435
    CrossrefPubMedGoogle Scholar
  • 18 Moake JL, McPherson PD. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome . Am J Med 1989; 87: 3-9N
    PubMedGoogle Scholar
  • 19 Ruggeri ZM, and Zimmerman TS. von Willebrand factor and von Willebrand disease. Blood 1987; 70: 895-904
    PubMedGoogle Scholar
  • 20 Moake JL, Turner NA, Stathopoulos NA, Nolasco LH, Helium JD. Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. J Clin Invest 1986; 78: 1456-1461
    CrossrefPubMedGoogle Scholar
  • 21 Moake JL, Turner NA, Stathopoulos NA, Nolasco LH, Heliums ID. Shear-induced platelet aggregation can be mediated by vWF released from platelets as well as by exogenous large or unusually large vWF multimers requires adenosine diphosphate and is resistant to aspirin. Blood 71: 1366-1374 1988;
    PubMedGoogle Scholar
  • 22 Frangos JA, Moake JL, Nolasco L, Phillips MD, Mclntire LV. Cryosupernatant regulates accumulation of unusually large vWF multimers from endothelial cells . Am J Physiol 1989; 256: H1635-H1644
    PubMedGoogle Scholar
  • 23 Phillips MD, Moake JL, Nolasco L, Garcia R. Plasma von Willebrand factor processing activity functions like a disulfide bond reductase reversible decrease of multimer size . Thromb Haemostasz 1993; 69: 2342a-2342a (Abst)
    PubMedGoogle Scholar
  • 24 Daghistani D, Jimenez JJ, Moake JL, Ledford MR, Yunis A. Familial relapsing thrombotic thrombocytopenic purpura . Ped Hematol-Oncology. 1995 in press
    PubMedGoogle Scholar
  • 25 Chow TW, Heliums JD, Moake JL, Kroll MH. Shear stress-induced von Willebrand factor binding to platelet glycoprotein lb initiates calcium influx associated with aggregation. Blood 1992; 80: 113-120
    PubMedGoogle Scholar
  • 26 Rock GA, Sumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RS, Spasoff RA. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 1991; 325: 393-397
    CrossrefPubMedGoogle Scholar
  • 27 Bell WR, Braine HG, Ness PM, Kickler TS. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome clinical experience in 108 patients. N Engl J Med 1991; 325: 398-402
    CrossrefPubMedGoogle Scholar
  • 28 Bukowski RM, Hewlett JS, Reimer RR, Groppe CW, Weick JK, Livingston RB. Therapy of thrombotic thrombocytopenic purpura An overview . Sem Thrombosis Hemostasis 1981; 7: 1-8
    PubMedGoogle Scholar
  • 29 Shepard KV, Bukowski RM. The treatment of thrombotic thrombo- cytopenic purpura with exchange transfusions plasma infusions and plasma exchange. Sem Hematol 1987; 24: 178-193
    PubMedGoogle Scholar
  • 30 Moake JL, Byrnes JJ, Troll JH, Rudy CK, Hong SL, Weinstein MJ, Colannino NM. Effects of fresh-frozen plasma and its cryosupernatant fraction on von Willebrand factor multimeric forms in chronic relapsing thrombotic thrombocytopenic purpura. Blood 1985; 65: 1232-1236
    CrossrefPubMedGoogle Scholar
  • 31 Byrnes JJ, Moake JL, Panpit K, Periman P. Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura. Am J Hematol 1990; 34: 169-174
    CrossrefPubMedGoogle Scholar
  • 32 Rock GA, Sutton D, Benny B, Shumack K, Nair R. and members of the Canadian apheresis group Cryosupernatant should be used in the treatment of thrombotic thrombocytopenic purpura. Blood 1994; 84: 971a-971a (Abst)
    PubMedGoogle Scholar
  • 33 Peterson DM, Stathopoulos NA, Giorgio TD, Heliums JD, Moake JL. Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins lb and Ilb/IIIa. Blood 1987; 69: 625-628
    PubMedGoogle Scholar